Your Gamete, Myself
By Marcy Darnovsky,
[Letter to the Editor] New York Times Magazine
| 08. 26. 2007
Peggy Orenstein's article (July 15) about the experiences of women who conceive and bear children using other women's eggs focuses on their frustrations about infertility, their desires for a pregnancy and a child and the difficulty of their decisions. I hope that you will soon give the same sort of sympathetic attention to the women who are providing these eggs. What is it like to undergo the grueling egg-retrieval process in exchange for a check? How thoroughly are these women being informed of the risks they are taking - including, as Orenstein briefly mentions, the possibility of adverse reactions requiring hospitalization and a small chance of death? Are they being told just how inadequate are the existing data about short-term and long-term risks? Who is recruiting them and profiting from the exchange? Orenstein's article concludes with the happiness of an egg-recipient mother-to-be, looking forward to building her family "regardless of whose genes are involved." Until we consider the women who are providing the eggs that carry those genes, that rosy wrap-up seems premature.
Marcy Darnovsky
Oakland, Calif.
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...